Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | May 31, 2023 09:06am

Gainers

  • Aridis Pharmaceuticals (NASDAQ:ARDS) shares increased by 98.9% to $0.37 during Wednesday's pre-market session. The market value of their outstanding shares is at $13.2 million.
  • VistaGen Therapeutics (NASDAQ:VTGN) stock increased by 38.98% to $0.19. The market value of their outstanding shares is at $40.8 million.
  • Marker Therapeutics (NASDAQ:MRKR) shares increased by 30.83% to $1.74. The market value of their outstanding shares is at $15.3 million.
  • Tenax Therapeutics (NASDAQ:TENX) stock moved upwards by 25.06% to $0.4. The market value of their outstanding shares is at $8.7 million.
  • Freeline Therapeutics (NASDAQ:FRLN) shares moved upwards by 15.99% to $2.9. The market value of their outstanding shares is at $12.5 million. The company's, Q1 earnings came out yesterday.
  • Akebia Therapeutics (NASDAQ:AKBA) shares rose 15.79% to $1.11. The market value of their outstanding shares is at $206.3 million.

Losers

  • Belite Bio (NASDAQ:BLTE) stock fell 44.0% to $13.39 during Wednesday's pre-market session. The market value of their outstanding shares is at $337.7 million.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares declined by 32.82% to $0.09. The company's market cap stands at $1.7 million.
  • Bellicum Pharmaceuticals (NASDAQ:BLCM) shares decreased by 25.09% to $0.57. The company's market cap stands at $5.4 million.
  • NeuBase Therapeutics (NASDAQ:NBSE) stock decreased by 19.93% to $0.14. The company's market cap stands at $4.7 million.
  • Aclarion (NASDAQ:ACON) stock declined by 15.86% to $0.88. The market value of their outstanding shares is at $6.9 million.
  • Phio Pharma (NASDAQ:PHIO) stock decreased by 13.9% to $3.47. The company's market cap stands at $5.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACON AKBA ARDS BDRX BLCM BLTE FRLN MRKR NBSE PHIO TENX VTGN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist